Share Price and Basic Stock Data
Last Updated: October 27, 2025, 4:04 pm
| PEG Ratio | 9.93 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Vera Synthetic Ltd operates in an unspecified industry and reported a market capitalization of ₹34.5 Cr, with a share price of ₹69.9. The company’s revenue trajectory illustrates significant fluctuations, with sales recorded at ₹40.70 Cr for the fiscal year ending March 2023, a substantial increase from ₹34.98 Cr in March 2022. However, the most recent quarter ending September 2023 showed a decline in sales to ₹21.55 Cr, down from ₹40.71 Cr in March 2023, indicating potential seasonal or operational challenges. The company’s sales have shown a volatile pattern over the years, peaking at ₹40.70 Cr in FY 2023, following a steady rise from ₹27.76 Cr in FY 2021. This revenue growth trend suggests a recovery post-pandemic; however, the recent dip in quarterly sales raises concerns about sustainability. The overall performance reflects a complex interplay of market dynamics, operational efficiency, and external economic factors.
Profitability and Efficiency Metrics
Vera Synthetic Ltd’s profitability metrics indicate a mixed performance. The operating profit margin (OPM) stood at 8.32%, while the net profit margin was recorded at 4.80% for the fiscal year ending March 2025. The return on equity (ROE) was reported at 9.07%, and the return on capital employed (ROCE) at 12.3%, both of which are relatively low compared to sector averages, suggesting room for improvement in capital efficiency. The interest coverage ratio (ICR) was extraordinarily high at 6735.86x, indicating a strong capacity to cover interest expenses, which is a significant strength. However, the cash conversion cycle (CCC) of 96.32 days reflects inefficiencies in managing working capital, particularly with inventory management and receivables. The company’s operating profit saw fluctuations, peaking at ₹2.93 Cr in March 2023, but dropped to ₹0.34 Cr in September 2023, highlighting volatility in operational performance.
Balance Sheet Strength and Financial Ratios
Vera Synthetic Ltd maintains a robust balance sheet, with total borrowings reported at ₹0.00 Cr, reflecting a debt-free status. This is complemented by reserves of ₹18.02 Cr, showcasing a strong equity base. The company’s current ratio was reported at 5.44, indicating a solid liquidity position, well above the typical sector benchmark of 1.5 or higher. The price-to-book value (P/BV) ratio stood at 1.42x, which is reasonable, suggesting the stock is fairly valued relative to its book value. Additionally, the asset turnover ratio of 1.68% reflects efficient utilization of assets to generate revenue. However, the increasing total liabilities, which rose to ₹26.74 Cr in March 2025 from ₹23.19 Cr in March 2023, could pose potential risks if not managed prudently. The company’s ability to maintain a strong reserve while managing liabilities will be crucial for future growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vera Synthetic Ltd reflects a strong promoter presence, with promoters holding 68.66% of the shares as of September 2023. This high level of promoter ownership typically signals investor confidence and stability, as it aligns the interests of management with those of shareholders. The public shareholding stands at 31.34%, showing a slight decline from previous periods, which may indicate a consolidation of ownership. The number of shareholders increased to 118 by March 2025, suggesting growing interest in the company. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could be a concern, as institutional backing often adds credibility and stability to a company’s stock. The reliance on public shareholders may expose the company to volatility, particularly if market conditions change unfavorably.
Outlook, Risks, and Final Insight
Vera Synthetic Ltd’s outlook appears mixed, with strengths in its robust balance sheet and operational capacity to cover interest expenses. However, the recent decline in sales, coupled with a high cash conversion cycle, poses risks to its profitability and operational efficiency. The lack of institutional investors may limit the company’s market credibility, potentially affecting future capital raising efforts. Investors should closely monitor the company’s ability to stabilize its revenue streams and improve operational efficiencies. Furthermore, the macroeconomic environment, including commodity price fluctuations and regulatory changes, could impact performance. In scenarios where the company successfully enhances its operational metrics and attracts institutional interest, it could see significant growth; conversely, failure to address operational challenges may lead to continued volatility in performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vera Synthetic Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 120 Cr. | 31.3 | 869/26.8 | 1.19 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,751 Cr. | 173 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 50.3 Cr. | 3.94 | 8.90/3.88 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,888.22 Cr | 233.07 | 355.69 | 218.84 | 0.23% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.01 | 15.56 | 14.70 | 13.43 | 17.40 | 17.58 | 19.61 | 40.71 | 21.55 | 21.56 | 23.28 | 19.11 |
| Expenses | 16.37 | 13.97 | 12.42 | 13.36 | 16.57 | 15.35 | 17.93 | 37.78 | 21.21 | 20.26 | 21.23 | 17.52 |
| Operating Profit | 1.64 | 1.59 | 2.28 | 0.07 | 0.83 | 2.23 | 1.68 | 2.93 | 0.34 | 1.30 | 2.05 | 1.59 |
| OPM % | 9.11% | 10.22% | 15.51% | 0.52% | 4.77% | 12.68% | 8.57% | 7.20% | 1.58% | 6.03% | 8.81% | 8.32% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.03 | 0.31 | -0.05 | 0.05 | 0.17 | 0.01 | 0.00 | 0.11 | 0.00 |
| Interest | 0.10 | 0.09 | 0.07 | 0.09 | 0.07 | 0.09 | 0.07 | 0.16 | 0.05 | 0.05 | 0.00 | 0.00 |
| Depreciation | 0.31 | 0.37 | 0.30 | 0.31 | 0.34 | 0.17 | 0.21 | 0.49 | 0.54 | 0.54 | 0.49 | 0.53 |
| Profit before tax | 1.23 | 1.13 | 1.91 | 0.70 | 0.73 | 1.92 | 1.45 | 2.45 | -0.24 | 0.71 | 1.67 | 1.06 |
| Tax % | 27.64% | 15.93% | 29.84% | 27.14% | 26.03% | 25.52% | 24.14% | 25.71% | 4.17% | 25.35% | 25.15% | 27.36% |
| Net Profit | 0.90 | 0.96 | 1.35 | 0.51 | 0.54 | 1.42 | 1.09 | 1.82 | -0.25 | 0.53 | 1.26 | 0.77 |
| EPS in Rs | 1.82 | 1.95 | 2.74 | 1.03 | 1.09 | 2.88 | 2.21 | 3.69 | -0.51 | 1.07 | 2.55 | 1.56 |
Last Updated: August 20, 2025, 1:30 am
Below is a detailed analysis of the quarterly data for Vera Synthetic Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 19.11 Cr.. The value appears to be declining and may need further review. It has decreased from 23.28 Cr. (Sep 2024) to 19.11 Cr., marking a decrease of 4.17 Cr..
- For Expenses, as of Mar 2025, the value is 17.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 21.23 Cr. (Sep 2024) to 17.52 Cr., marking a decrease of 3.71 Cr..
- For Operating Profit, as of Mar 2025, the value is 1.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.05 Cr. (Sep 2024) to 1.59 Cr., marking a decrease of 0.46 Cr..
- For OPM %, as of Mar 2025, the value is 8.32%. The value appears to be declining and may need further review. It has decreased from 8.81% (Sep 2024) to 8.32%, marking a decrease of 0.49%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.11 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.53 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.49 Cr. (Sep 2024) to 0.53 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 1.67 Cr. (Sep 2024) to 1.06 Cr., marking a decrease of 0.61 Cr..
- For Tax %, as of Mar 2025, the value is 27.36%. The value appears to be increasing, which may not be favorable. It has increased from 25.15% (Sep 2024) to 27.36%, marking an increase of 2.21%.
- For Net Profit, as of Mar 2025, the value is 0.77 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Sep 2024) to 0.77 Cr., marking a decrease of 0.49 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.56. The value appears to be declining and may need further review. It has decreased from 2.55 (Sep 2024) to 1.56, marking a decrease of 0.99.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 24.32 | 21.89 | 18.13 | 22.15 | 33.73 | 32.29 | 27.76 | 34.98 | 40.70 | 39.38 | 42.03 |
| Expenses | 18.67 | 23.37 | 21.02 | 17.17 | 19.86 | 31.03 | 29.22 | 25.43 | 31.93 | 37.77 | 35.74 | 38.60 |
| Operating Profit | 0.91 | 0.95 | 0.87 | 0.96 | 2.29 | 2.70 | 3.07 | 2.33 | 3.05 | 2.93 | 3.64 | 3.43 |
| OPM % | 4.65% | 3.91% | 3.97% | 5.30% | 10.34% | 8.00% | 9.51% | 8.39% | 8.72% | 7.20% | 9.24% | 8.16% |
| Other Income | 0.18 | 0.18 | 0.06 | 0.02 | 0.10 | 0.17 | 0.17 | 1.05 | 0.26 | 0.17 | 0.07 | 0.33 |
| Interest | 0.33 | 0.35 | 0.13 | 0.10 | 0.37 | 0.25 | 0.19 | 0.16 | 0.16 | 0.16 | 0.08 | 0.00 |
| Depreciation | 0.28 | 0.38 | 0.40 | 0.26 | 0.48 | 0.65 | 0.67 | 0.61 | 0.51 | 0.49 | 1.18 | 1.02 |
| Profit before tax | 0.48 | 0.40 | 0.40 | 0.62 | 1.54 | 1.97 | 2.38 | 2.61 | 2.64 | 2.45 | 2.45 | 2.74 |
| Tax % | 31.25% | 90.00% | 32.50% | 32.26% | 31.17% | 28.93% | 21.85% | 28.74% | 25.76% | 25.71% | 27.35% | 25.91% |
| Net Profit | 0.33 | 0.05 | 0.27 | 0.43 | 1.06 | 1.40 | 1.85 | 1.86 | 1.97 | 1.82 | 1.80 | 2.03 |
| EPS in Rs | 1.83 | 0.28 | 1.50 | 2.39 | 2.94 | 2.84 | 3.75 | 3.77 | 3.99 | 3.69 | 3.65 | 4.11 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -84.85% | 440.00% | 59.26% | 146.51% | 32.08% | 32.14% | 0.54% | 5.91% | -7.61% | -1.10% | 12.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 524.85% | -380.74% | 87.25% | -114.44% | 0.07% | -31.60% | 5.37% | -13.53% | 6.52% | 13.88% |
Vera Synthetic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.40 | -0.32 | 0.06 | 0.11 | -2.72 | 0.94 | 1.67 | 0.51 | 1.37 | 1.80 | 3.64 | 3.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.81 | 46.83 | 45.69 | 36.04 | 136.28 | 82.67 | 92.01 | 83.36 | 89.01 | 82.15 | 27.06 | 37.95 |
| Inventory Days | 50.65 | 13.18 | 21.15 | 31.97 | 38.30 | 5.46 | 28.52 | 51.60 | 30.23 | 38.86 | 68.81 | 84.39 |
| Days Payable | 11.54 | 10.23 | 16.10 | 7.05 | 81.62 | 16.38 | 23.50 | 33.41 | 37.57 | 14.65 | 7.57 | 26.02 |
| Cash Conversion Cycle | 93.91 | 49.77 | 50.74 | 60.97 | 92.96 | 71.76 | 97.02 | 101.55 | 81.67 | 106.36 | 88.30 | 96.32 |
| Working Capital Days | 36.54 | 20.86 | 23.18 | 5.44 | 45.98 | 70.01 | 86.02 | 117.68 | 134.61 | 101.88 | 80.17 | 143.99 |
| ROCE % | 12.31% | 9.86% | 14.04% | 25.18% | 18.82% | 17.96% | 16.47% | 15.48% | 13.29% | 12.28% | 12.26% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Diluted EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Cash EPS (Rs.) | 6.18 | 6.02 | 4.67 | 5.01 | 4.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Revenue From Operations / Share (Rs.) | 85.44 | 79.80 | 82.48 | 70.89 | 56.95 |
| PBDIT / Share (Rs.) | 7.62 | 7.53 | 6.28 | 6.71 | 6.85 |
| PBIT / Share (Rs.) | 5.54 | 5.15 | 5.30 | 5.68 | 5.62 |
| PBT / Share (Rs.) | 5.54 | 4.98 | 4.97 | 5.36 | 5.29 |
| Net Profit / Share (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| PBDIT Margin (%) | 8.91 | 9.43 | 7.61 | 9.46 | 12.03 |
| PBIT Margin (%) | 6.48 | 6.44 | 6.42 | 8.01 | 9.86 |
| PBT Margin (%) | 6.48 | 6.24 | 6.02 | 7.56 | 9.28 |
| Net Profit Margin (%) | 4.80 | 4.56 | 4.46 | 5.62 | 6.60 |
| Return on Networth / Equity (%) | 8.83 | 8.58 | 9.51 | 11.36 | 12.09 |
| Return on Capital Employeed (%) | 11.91 | 12.13 | 13.28 | 15.23 | 16.66 |
| Return On Assets (%) | 7.57 | 7.65 | 7.84 | 8.36 | 9.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.09 | 0.08 |
| Asset Turnover Ratio (%) | 1.68 | 1.69 | 1.74 | 1.59 | 1.45 |
| Current Ratio (X) | 5.44 | 6.58 | 4.80 | 3.95 | 4.00 |
| Quick Ratio (X) | 3.72 | 4.56 | 3.91 | 3.55 | 3.38 |
| Inventory Turnover Ratio (X) | 4.08 | 4.29 | 7.26 | 5.38 | 4.94 |
| Interest Coverage Ratio (X) | 6735.86 | 44.96 | 19.25 | 21.30 | 20.70 |
| Interest Coverage Ratio (Post Tax) (X) | 3633.34 | 22.73 | 12.29 | 13.66 | 12.35 |
| Enterprise Value (Cr.) | 32.30 | 20.24 | 35.29 | 12.33 | 14.28 |
| EV / Net Operating Revenue (X) | 0.76 | 0.51 | 0.86 | 0.35 | 0.50 |
| EV / EBITDA (X) | 8.59 | 5.45 | 11.38 | 3.73 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| Price / BV (X) | 1.42 | 1.23 | 1.89 | 0.74 | 1.04 |
| Price / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| EarningsYield | 0.06 | 0.06 | 0.05 | 0.15 | 0.11 |
After reviewing the key financial ratios for Vera Synthetic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 6.02 (Mar 24) to 6.18, marking an increase of 0.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.44. It has increased from 79.80 (Mar 24) to 85.44, marking an increase of 5.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 7.53 (Mar 24) to 7.62, marking an increase of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 5.54, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.54, marking an increase of 0.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For PBDIT Margin (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 9.43 (Mar 24) to 8.91, marking a decrease of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 6.48, marking an increase of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.24 (Mar 24) to 6.48, marking an increase of 0.24.
- For Net Profit Margin (%), as of Mar 25, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.56 (Mar 24) to 4.80, marking an increase of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 15. It has increased from 8.58 (Mar 24) to 8.83, marking an increase of 0.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 12.13 (Mar 24) to 11.91, marking a decrease of 0.22.
- For Return On Assets (%), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 7.57, marking a decrease of 0.08.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.68. It has decreased from 1.69 (Mar 24) to 1.68, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.44. This value exceeds the healthy maximum of 3. It has decreased from 6.58 (Mar 24) to 5.44, marking a decrease of 1.14.
- For Quick Ratio (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 2. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.29 (Mar 24) to 4.08, marking a decrease of 0.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6,735.86. This value is within the healthy range. It has increased from 44.96 (Mar 24) to 6,735.86, marking an increase of 6,690.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3,633.34. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 3,633.34, marking an increase of 3,610.61.
- For Enterprise Value (Cr.), as of Mar 25, the value is 32.30. It has increased from 20.24 (Mar 24) to 32.30, marking an increase of 12.06.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.76, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 8.59. This value is within the healthy range. It has increased from 5.45 (Mar 24) to 8.59, marking an increase of 3.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.42, marking an increase of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vera Synthetic Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.91% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.83% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3633.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.3 (Industry average Stock P/E: 355.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Synthetic/Silk | Office No.UL-27, Pattani Plaza, Bhavnagar Gujarat 364002 | info@sujlonropes.com http://www.sujlonropes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunil D Makwana | Chairman & Managing Director |
| Mrs. Meera S Makwana | Whole Time Director |
| Mr. Devjibhai P Makwana | Executive Director |
| Mr. Dineshbhai M Patel | Independent Director |
| Mrs. Bansari Parin Shah | Independent Director |
| Mr. Ravikumar B Adhiya | Independent Director |